ITC to hear Roche claim against Organon Teknika alleging quantitative HIV test patent infringement.
This article was originally published in The Gray Sheet
Executive Summary
ITC TO HEAR ROCHE'S COMPLAINT AGAINST ORGANON TEKNIKA for allegedly infringing technology in its quantitative HIV RNA load polymerase chain reaction test. In a Federal Register notice to be published the week of July 29, the International Trade Commission says it decided July 22 to hear Nutley, New Jersey-based Hoffmann-La Roche's complaint against Organon Teknika B.V. of the Netherlands and its Durham, North Carolina subsidiary, Organon Teknika Corporation. Roche alleges that Organon's NASBA HIV-1 RNA QT kit infringes Roche's U.S. patent on technology which allows precise quantification of nucleic acids. Roche is requesting the ITC to bar import of Organon's kits into the U.S. Organon is importing the tests for research use.